SRC and neoplasm: Overexpression and/or activation of Src have been frequently detected in a variety of tumors arising from the lung, breast, colon, prostate, and pancreas [18, 20], and hyperactivity of Src is correlated with tumor progression, metastasis, and poor prognosis [21].